Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 284.20
+28.20 (11.02%)
At close: Mar 27, 2026
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 25.62 billion as of March 27, 2026.
Market Cap
25.62B
Enterprise Value
22.03B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
284.20
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 25.62B, an increase of 46.26%. That is a compound annual growth rate of 49.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 25.62B | -3.92% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 37.87B |
| Shanghai Henlius Biotech | 36.50B |
| Shanghai Junshi Biosciences | 33.84B |
| TransThera Sciences (Nanjing) | 27.47B |
| InnoCare Pharma | 25.04B |
| Genscript Biotech | 24.07B |
| PegBio | 23.70B |
| Keymed Biosciences | 16.95B |